NPI: 1033107214 · EDMONDS, WA 98026 · Psychiatric Hospital Unit · NPI assigned 10/11/2005
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECREATRY FOR ENROLLMENT) |
| NPI Enumeration Date | 10/11/2005 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 155,207 | $4.63M |
| 2019 | 157,421 | $4.58M |
| 2020 | 137,621 | $3.71M |
| 2021 | 167,166 | $4.42M |
| 2022 | 159,616 | $4.23M |
| 2023 | 172,362 | $4.52M |
| 2024 | 146,009 | $3.99M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 15,185 | 12,974 | $4.41M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 33,267 | 31,185 | $3.70M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 31,103 | 28,723 | $2.73M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 28,628 | 26,230 | $2.36M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 24,962 | 18,960 | $1.68M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 7,429 | 7,154 | $1.25M |
| 70450 | Computed tomography, head or brain; without contrast material | 6,830 | 6,470 | $813K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 4,001 | 3,944 | $813K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8,224 | 7,825 | $705K |
| 59025 | Fetal non-stress test | 3,874 | 2,724 | $633K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,694 | 1,664 | $572K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,479 | 2,007 | $520K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 5,361 | 4,483 | $480K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 809 | 795 | $438K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 4,291 | 4,029 | $423K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4,966 | 4,725 | $414K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,418 | 2,329 | $379K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,296 | 2,212 | $365K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 11,643 | 10,355 | $361K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2,944 | 2,805 | $358K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 4,076 | 3,933 | $350K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 670 | 667 | $317K |
| 76642 | 3,412 | 3,147 | $288K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 10,788 | 5,477 | $245K |
| 29581 | 1,631 | 454 | $233K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 790 | 768 | $227K |
| 76830 | Ultrasound, transvaginal | 2,561 | 2,496 | $205K |
| 80053 | Comprehensive metabolic panel | 47,450 | 42,034 | $191K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 4,683 | 4,659 | $173K |
| 93017 | 2,206 | 2,168 | $172K | |
| 47562 | 70 | 69 | $166K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 533 | 521 | $155K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 619 | 603 | $131K |
| 12001 | 614 | 606 | $123K | |
| 93350 | 646 | 641 | $123K | |
| 70498 | 1,316 | 1,271 | $118K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2,809 | 2,734 | $117K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4,599 | 4,299 | $105K |
| 95811 | 240 | 239 | $104K | |
| 97535 | Self-care/home management training, each 15 minutes | 5,329 | 3,836 | $102K |
| 70496 | 1,355 | 1,306 | $98K | |
| 93970 | 981 | 950 | $94K | |
| 76801 | 1,991 | 1,800 | $93K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 5,003 | 2,797 | $90K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 625 | 612 | $90K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 3,697 | 2,301 | $85K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4,019 | 2,286 | $83K |
| 10060 | 367 | 355 | $77K | |
| 84484 | 19,233 | 15,458 | $76K | |
| 97162 | 1,882 | 1,834 | $74K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 16,180 | 14,019 | $73K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 499 | 316 | $70K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 117 | 116 | $69K |
| 77066 | Tomosynthesis, mammo | 2,303 | 2,269 | $65K |
| 77065 | Tomosynthesis, mammo | 2,083 | 1,927 | $64K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 4,006 | 3,986 | $58K |
| G0378 | Hospital observation service, per hour | 10,865 | 4,441 | $56K |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 79 | 78 | $53K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 5,208 | 4,692 | $50K |
| 71046 | Radiologic examination, chest; 2 views | 9,053 | 8,736 | $49K |
| 83605 | 10,482 | 8,778 | $47K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1,004 | 966 | $47K |
| 93321 | 654 | 648 | $46K | |
| 84443 | Thyroid stimulating hormone (TSH) | 8,800 | 8,547 | $38K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,828 | 2,746 | $37K |
| 97161 | 1,063 | 1,039 | $37K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,428 | 1,320 | $35K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 61,207 | 53,109 | $35K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 246 | 243 | $35K |
| 93971 | 406 | 393 | $33K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,677 | 1,633 | $33K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2,265 | 2,194 | $32K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 26,686 | 23,974 | $30K |
| 87631 | 585 | 565 | $29K | |
| 76536 | 329 | 327 | $27K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,249 | 2,150 | $26K |
| 87040 | 4,542 | 2,785 | $26K | |
| 12011 | 133 | 129 | $25K | |
| 80061 | Lipid panel | 5,749 | 5,670 | $24K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,797 | 1,765 | $24K |
| 83880 | 4,626 | 4,313 | $24K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 24,955 | 20,479 | $24K |
| 93325 | 865 | 858 | $23K | |
| 70491 | 131 | 129 | $23K | |
| 36415 | Collection of venous blood by venipuncture | 32,000 | 25,719 | $22K |
| 84145 | 2,803 | 2,509 | $20K | |
| 90715 | 1,176 | 1,151 | $20K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 3,549 | 3,505 | $19K |
| 85379 | 3,603 | 3,510 | $18K | |
| 76770 | 211 | 203 | $18K | |
| 72100 | 1,546 | 1,510 | $17K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,787 | 1,716 | $16K |
| 83036 | Hemoglobin; glycosylated (A1C) | 8,022 | 7,902 | $16K |
| 82728 | 2,745 | 2,709 | $15K | |
| 80047 | 3,228 | 3,108 | $15K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 7,985 | 7,565 | $15K |
| 93978 | 358 | 344 | $15K | |
| 87507 | 202 | 196 | $14K | |
| 73030 | 1,871 | 1,695 | $13K | |
| 80050 | General health panel | 2,471 | 2,463 | $13K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 368 | 324 | $12K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 920 | 896 | $12K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,823 | 2,740 | $12K |
| 86780 | 2,253 | 2,226 | $12K | |
| 86803 | 1,764 | 1,744 | $12K | |
| 87634 | 681 | 674 | $11K | |
| 84702 | 6,344 | 5,581 | $11K | |
| 74018 | 1,432 | 1,312 | $11K | |
| 71045 | Radiologic examination, chest; single view | 12,253 | 11,406 | $10K |
| 19083 | 12 | 12 | $10K | |
| 73630 | 1,943 | 1,804 | $10K | |
| 82607 | 1,687 | 1,667 | $10K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 164 | 98 | $10K |
| 85027 | 5,217 | 4,596 | $9K | |
| 97597 | 98 | 74 | $9K | |
| 73564 | 2,060 | 1,859 | $8K | |
| 49083 | 43 | 24 | $8K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1,875 | 1,854 | $8K |
| 95819 | 51 | 50 | $8K | |
| 86140 | 5,412 | 4,725 | $8K | |
| 82553 | 1,328 | 1,234 | $8K | |
| 84439 | 2,106 | 2,047 | $8K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 12 | 12 | $8K |
| 73130 | 1,482 | 1,336 | $8K | |
| 81001 | 26,101 | 24,235 | $8K | |
| 73610 | 1,982 | 1,863 | $8K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2,101 | 2,079 | $7K |
| 64483 | 13 | 13 | $7K | |
| 84466 | 1,830 | 1,810 | $7K | |
| 29125 | 28 | 26 | $7K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 15 | 12 | $7K |
| 87158 | 797 | 723 | $7K | |
| 70486 | 205 | 201 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 10,009 | 7,660 | $7K |
| 62323 | 27 | 27 | $6K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 62 | 62 | $5K |
| 84153 | 712 | 708 | $5K | |
| 71250 | 137 | 133 | $5K | |
| 73502 | 775 | 743 | $5K | |
| 82962 | 22,980 | 14,718 | $5K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 71 | 66 | $5K |
| 36430 | 122 | 101 | $5K | |
| 83540 | 1,839 | 1,819 | $5K | |
| 86762 | 1,056 | 1,043 | $5K | |
| 84403 | 657 | 651 | $4K | |
| 73110 | 1,097 | 1,029 | $4K | |
| 97116 | 380 | 244 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 18,209 | 14,559 | $4K |
| 97802 | 66 | 66 | $4K | |
| 83735 | 6,170 | 5,093 | $4K | |
| 83970 | 243 | 235 | $4K | |
| 80076 | 1,268 | 1,198 | $4K | |
| 76870 | 45 | 43 | $4K | |
| 87340 | 1,402 | 1,374 | $4K | |
| 86850 | 3,068 | 2,883 | $3K | |
| 86480 | 271 | 246 | $3K | |
| 83690 | 15,654 | 14,288 | $3K | |
| 97803 | 87 | 69 | $3K | |
| 12002 | 24 | 24 | $3K | |
| 84146 | 485 | 482 | $3K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 2,744 | 970 | $3K |
| 97035 | 433 | 237 | $3K | |
| 73562 | 95 | 89 | $3K | |
| 85652 | 3,467 | 3,068 | $3K | |
| 87503 | 605 | 547 | $3K | |
| 86901 | 3,975 | 3,573 | $3K | |
| 82746 | 560 | 553 | $3K | |
| 86900 | 3,896 | 3,480 | $2K | |
| 87186 | 2,334 | 2,228 | $2K | |
| 83001 | 493 | 492 | $2K | |
| 87205 | 2,281 | 2,019 | $2K | |
| 85610 | 5,758 | 4,624 | $2K | |
| 82950 | 649 | 644 | $2K | |
| 82570 | 1,181 | 1,107 | $2K | |
| 87070 | 2,068 | 1,889 | $2K | |
| 87077 | 1,665 | 1,577 | $2K | |
| 87660 | 423 | 412 | $2K | |
| 82670 | 288 | 287 | $2K | |
| 80143 | 188 | 179 | $2K | |
| 84481 | 667 | 653 | $2K | |
| 73140 | 224 | 216 | $2K | |
| 97165 | 53 | 52 | $2K | |
| 87081 | 1,176 | 1,165 | $2K | |
| 82043 | 829 | 824 | $2K | |
| 86787 | 312 | 307 | $1K | |
| 82075 | 1,382 | 1,242 | $1K | |
| 82565 | 1,266 | 1,178 | $1K | |
| 87641 | 233 | 212 | $1K | |
| 72131 | 52 | 52 | $1K | |
| 71101 | 249 | 243 | $1K | |
| 96376 | 7,023 | 5,379 | $1K | |
| 94726 | 27 | 27 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,353 | 1,305 | $1K |
| 87480 | 423 | 412 | $1K | |
| 82077 | 1,978 | 1,793 | $1K | |
| 97163 | 26 | 26 | $1K | |
| 87510 | 423 | 412 | $1K | |
| 84100 | 1,776 | 1,418 | $1K | |
| 82550 | 2,878 | 2,532 | $1K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 15 | 15 | $1K |
| 84550 | 644 | 625 | $995.15 | |
| 73080 | 232 | 220 | $991.92 | |
| 86706 | 252 | 246 | $991.05 | |
| 73590 | 292 | 272 | $959.41 | |
| 84703 | 6,126 | 5,872 | $941.83 | |
| 81025 | 5,635 | 5,424 | $941.43 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 8,434 | 7,546 | $906.56 |
| 94729 | 40 | 40 | $903.03 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2,976 | 2,889 | $895.00 |
| 72040 | 52 | 50 | $889.19 | |
| 83002 | 187 | 187 | $832.22 | |
| 85014 | 552 | 459 | $729.53 | |
| 86364 | 112 | 109 | $680.37 | |
| 86677 | 145 | 141 | $671.89 | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 887 | 874 | $666.84 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 16,430 | 13,858 | $660.33 |
| 84156 | 356 | 317 | $613.11 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 13,787 | 12,021 | $605.09 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 14,013 | 13,009 | $600.25 |
| 87430 | 951 | 943 | $576.72 | |
| 87210 | 1,436 | 1,293 | $573.91 | |
| 80179 | 604 | 588 | $567.30 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 7,987 | 5,680 | $546.20 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3,187 | 3,085 | $521.91 |
| 82803 | 3,115 | 2,741 | $437.13 | |
| 86923 | 31 | 30 | $436.07 | |
| 82105 | 62 | 62 | $416.35 | |
| 87147 | 348 | 329 | $401.46 | |
| 87653 | 21 | 21 | $364.57 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 6,626 | 5,295 | $363.92 |
| 81003 | 1,311 | 1,229 | $361.08 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,612 | 1,392 | $360.37 |
| 93798 | 62 | 12 | $321.26 | |
| 86038 | 90 | 81 | $320.15 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 7,203 | 6,120 | $318.38 |
| 90686 | 32 | 32 | $305.71 | |
| 82784 | 111 | 95 | $304.04 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 41 | 38 | $303.07 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 6,409 | 6,019 | $301.67 |
| 84402 | 67 | 67 | $286.35 | |
| 87075 | 610 | 539 | $268.82 | |
| 74019 | 16 | 13 | $260.88 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 6,917 | 5,851 | $246.00 |
| 87188 | 1,149 | 1,091 | $244.78 | |
| 86376 | 59 | 57 | $240.12 | |
| C1769 | Guide wire | 951 | 864 | $230.74 |
| 99153 | Mod sedat endo service >5yrs | 806 | 779 | $220.55 |
| 85730 | 1,858 | 1,736 | $206.68 | |
| 73090 | 52 | 49 | $205.39 | |
| 82951 | 26 | 26 | $204.00 | |
| 87338 | 39 | 39 | $202.32 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 5,690 | 5,128 | $201.23 |
| J2704 | Injection, propofol, 10 mg | 6,821 | 6,611 | $188.40 |
| 87220 | 515 | 505 | $171.15 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 6,390 | 4,225 | $160.51 |
| 88342 | 413 | 397 | $152.32 | |
| A9585 | Injection, gadobutrol, 0.1 ml | 1,745 | 1,685 | $149.88 |
| 80178 | 27 | 25 | $148.58 | |
| 80069 | 28 | 27 | $144.60 | |
| 85018 | 163 | 124 | $134.59 | |
| J3490 | Unclassified drugs | 916 | 860 | $131.98 |
| 88304 | 1,010 | 996 | $129.31 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 808 | 773 | $125.03 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 895 | 886 | $123.65 |
| 99152 | 715 | 682 | $120.37 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,511 | 3,089 | $113.97 |
| 80164 | 29 | 25 | $109.05 | |
| 87486 | 12 | 12 | $106.92 | |
| 36591 | 38 | 28 | $99.76 | |
| G0379 | Direct admission of patient for hospital observation care | 26 | 25 | $98.36 |
| G0008 | Administration of influenza virus vaccine | 13 | 13 | $95.04 |
| 84445 | 16 | 14 | $94.12 | |
| 86735 | 27 | 25 | $88.73 | |
| A9270 | Non-covered item or service | 17,338 | 3,250 | $88.06 |
| 0353U | 1,274 | 1,256 | $87.83 | |
| J2060 | Injection, lorazepam, 2 mg | 3,476 | 2,890 | $86.86 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,675 | 1,481 | $83.95 |
| J2785 | Injection, regadenoson, 0.1 mg | 340 | 327 | $83.45 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,632 | 1,529 | $82.36 |
| J3370 | Injection, vancomycin hcl, 500 mg | 1,059 | 717 | $78.63 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 338 | 326 | $75.08 |
| 86765 | 25 | 24 | $73.74 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 805 | 738 | $73.53 |
| J1815 | Injection, insulin, per 5 units | 3,502 | 1,166 | $69.92 |
| 82533 | 14 | 14 | $68.51 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 12 | 12 | $66.15 |
| 87581 | 12 | 12 | $66.15 | |
| 82247 | 16 | 13 | $65.73 | |
| 0352U | 539 | 528 | $64.48 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 844 | 746 | $61.24 |
| 84144 | 13 | 13 | $60.67 | |
| 82010 | 459 | 423 | $57.34 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 3,237 | 2,917 | $55.63 |
| 74022 | 59 | 58 | $54.67 | |
| J7050 | Infusion, normal saline solution, 250 cc | 5,991 | 4,602 | $54.35 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 4,998 | 4,275 | $54.33 |
| 83615 | 24 | 24 | $42.89 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 735 | 711 | $40.07 |
| 86703 | 14 | 12 | $39.96 | |
| 86704 | 13 | 13 | $35.50 | |
| 82977 | 12 | 12 | $31.75 | |
| 82248 | 14 | 13 | $28.33 | |
| 82140 | 28 | 24 | $25.82 | |
| 86308 | 52 | 51 | $18.76 | |
| 95249 | 95 | 95 | $16.27 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 2,691 | 2,198 | $14.19 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 33 | 32 | $13.27 |
| 87071 | 39 | 36 | $11.56 | |
| J1630 | Injection, haloperidol, up to 5 mg | 617 | 496 | $11.06 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 922 | 611 | $10.66 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 829 | 819 | $6.80 |
| 87046 | 12 | 12 | $6.29 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2,624 | 2,495 | $5.72 |
| 84520 | 14 | 12 | $3.53 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,466 | 1,082 | $2.82 |
| C9113 | Injection, pantoprazole sodium, per vial | 380 | 206 | $2.68 |
| J1644 | Injection, heparin sodium, per 1000 units | 4,181 | 2,036 | $2.39 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 326 | 312 | $1.81 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 160 | 158 | $0.25 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 987 | 950 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 676 | 649 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 427 | 377 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 16,866 | 12,336 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 138 | 90 | $0.00 |
| 87150 | 299 | 294 | $0.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 103 | 99 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 737 | 702 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 78 | 77 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 99 | 97 | $0.00 |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 80 | 78 | $0.00 |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 88 | 40 | $0.00 |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 12 | 12 | $0.00 |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | 77 | 75 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 94 | 82 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 29 | 26 | $0.00 |
| 93356 | 12 | 12 | $0.00 | |
| C1758 | Catheter, ureteral | 13 | 12 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 137 | 134 | $0.00 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 68 | 67 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 482 | 432 | $0.00 |
| G8981 | Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals | 145 | 141 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 244 | 234 | $0.00 |
| 0240U | 117 | 116 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 227 | 215 | $0.00 |
| G8982 | Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 185 | 179 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 30 | 28 | $0.00 |
| J1597 | Injection, glycopyrrolate (glyrx-pf), 0.1 mg | 38 | 37 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 91 | 84 | $0.00 |
| J1836 | Injection, metronidazole, 10 mg | 376 | 295 | $0.00 |
| J3411 | Injection, thiamine hcl, 100 mg | 58 | 31 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 60 | 41 | $0.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 109 | 101 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 43 | 43 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 19 | 15 | $0.00 |
| 36416 | 214 | 211 | $0.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 29 | 28 | $0.00 |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 13 | 13 | $0.00 |
| 88341 | 18 | 16 | $0.00 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 32 | 13 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 78 | 63 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 12 | 12 | $0.00 |
| A4648 | Tissue marker, implantable, any type, each | 34 | 25 | $0.00 |